Geode Capital Management LLC raised its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 1.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,415,022 shares of the company’s stock after acquiring an additional 23,178 shares during the period. Geode Capital Management LLC owned approximately 2.01% of Privia Health Group worth $43,986,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of PRVA. Sequoia Financial Advisors LLC raised its stake in Privia Health Group by 2.3% during the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after purchasing an additional 583 shares in the last quarter. Benjamin F. Edwards & Company Inc. increased its holdings in shares of Privia Health Group by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock worth $134,000 after buying an additional 605 shares during the last quarter. Arizona State Retirement System raised its position in shares of Privia Health Group by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock valued at $462,000 after buying an additional 617 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after acquiring an additional 626 shares during the last quarter. Finally, Parkside Financial Bank & Trust grew its position in Privia Health Group by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock worth $151,000 after acquiring an additional 771 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have issued reports on PRVA shares. Barclays upped their price objective on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Macquarie assumed coverage on Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target on the stock. Robert W. Baird raised their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Finally, KeyCorp began coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $24.80.
Privia Health Group Stock Down 0.8 %
Shares of NASDAQ PRVA opened at $19.91 on Tuesday. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $24.30. The firm has a market cap of $2.39 billion, a PE ratio of 199.12, a price-to-earnings-growth ratio of 5.45 and a beta of 0.83. The business has a fifty day simple moving average of $20.30 and a two-hundred day simple moving average of $19.16.
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Read More
- Five stocks we like better than Privia Health Group
- How Technical Indicators Can Help You Find Oversold Stocks
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- How to Find Undervalued Stocks
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Canada Bond Market Holiday: How to Invest and Trade
- Market Overreaction: 2 Stocks to Buy on the Way Down
Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVA – Free Report).
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.